Recent Posts

• A history of hyperthermia therapy (part I)
• Short-term use of HIVEC in intermediate risk bladder-cancer patients is non-inferior to classical treatments and longer-term use shows great promise in Spanish trial
• “If we could kill the tumour without radical surgery, boy would that be a boon for patients. And I think that’s where we are headed”
• Growing data points towards use of HIVEC® in high-risk and BCG-unresponsive patients following publication of HIVEC® bladder cancer RCT results
• “There’s a new vitality in bladder cancer. And it’s exciting to have come through 20 years of agony and start to see the fruits of all that labour”